Endoscopy 2010; 42(6): 503-515
DOI: 10.1055/s-0029-1244208
Guidelines

© Georg Thieme Verlag KG Stuttgart · New York

European Society of Gastrointestinal Endoscopy (ESGE)Guideline: Prophylaxis of post-ERCP pancreatitis

J.-M.  Dumonceau1 , A.  Andriulli2 , J.  Deviere3 , A.  Mariani4 , J.  Rigaux3 , T.  H.  Baron5 , P.  A.  Testoni4
  • 1Service of Gastroenterology and Hepatology, Geneva University Hospitals, Geneva, Switzerland
  • 2Division of Gastroenterology, Casa Sollievo Sofferemza Hospital, IRCCS, San Giovanni Rotondo, Italy
  • 3Departments of Gastroenterology and Hepato-Pancreatology, Erasme University Hospital, Brussels, Belgium
  • 4Division of Gastroenterology and Gastrointestinal Endoscopy, Vita-Salute San Raffaele University, IRCCS San Raffaele Hospital, Milan, Italy
  • 5Department of Medicine, Division of Gastroenterology and Hepatology, Mayo Medical Center, Rochester, Minnesota, USA
Further Information

Publication History

submitted 7 January 2010

accepted after revision 15 March 2010

Publication Date:
26 May 2010 (online)

Preview

Pancreatitis is the most common complication of endoscopic retrograde cholangiopancreatography (ERCP). Risk factors for post-ERCP pancreatitis (PEP) are both patient-related and procedure-related. Identification of patients at high risk for PEP is important in order to target prophylactic measures. Prevention of PEP includes administration of nonsteroidal inflammatory drugs (NSAIDs), use of specific cannulation techniques, and placement of temporary pancreatic stents. The aim of this guideline commissioned by the European Society of Gastrointestinal Endoscopy (ESGE) is to provide practical, graded, recommendations for the prevention of PEP.

References

J.-M. DumonceauMD, PhD 

Division of Gastroenterology and Hepatology
Geneva University Hospitals

rue Micheli-du-Crest 24
1205 Geneva
Switzerland

Fax: +41-22-3729366

Email: jmdumonceau@hotmail.com